Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-003556
Filing Date
2025-04-10
Accepted
2025-04-10 13:30:33
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3342
  Complete submission text file 0001641172-25-003556.txt   5019
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BIODELIVERY SCIENCES INTERNATIONAL 4131 PARK LAKE AVE., SUITE 225 RALEIGH NC 27612
Business Address
Vasisht Niraj (Reporting) CIK: 0001662930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13467 | Film No.: 25827657